- April 26, 2012
- April 25, 2012
- April 19, 2012
Innate Pharma is pleased to draw your attention to an initiation note that Life Science Advisors have published on the Company.
To view the research note please visit LSA’s website
- July 6, 2011
- November 5, 2010
- October 23, 2011
Nobel Prize for Medicine awarded to Ralph Steinman (Rockefeller, US), Bruce Beutler (Scripps, US) and Jules Hoffmann (Strasbourg, France).
Recognition of Beutler and Hoffman’s “discoveries concerning the activation of innate immunity” and Steinman’s work for his discovery of the dendritic cell and its role in adaptive immunity.
Their work has opened up new avenues for the development of new therapies against infections, cancer, and inflammatory diseases.
- October 25, 2011
Moderator: Jason Kantor, PhD, Managing Director, RBC Capital Markets
Hervé Brailly, PhD, Chief Executive Officer, Innate Pharma SA,
Kevin N. Heller, MD, Director, Immuno-Oncology- Strategic Transactions Group, Bristol-Myers Squibb Company
Carlos Paya, MD, PhD, President & Chief Executive Officer, Immune Design Corp.
Timothy C. Rodell, MD, Chief Executive Officer & President, Globeimmune, Inc
- November 24, 2011
- December 9, 2011
- January 20, 2012
A research lead by Eric Vivier and Sophie Ugolini of the Centre d'Immunologie de Marseille-Luminy (CIML - Inserm/CNRS/Aix Marseille Université) has revealed a new gene that, when mutated, stimulates the immune systems to fight better against tumours and viral infections.